Literature DB >> 15254283

Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas.

Berthold Streubel1, Andreas Chott, Daniela Huber, Markus Exner, Ulrich Jäger, Oswald Wagner, Ilse Schwarzinger.   

Abstract

BACKGROUND: The growth of most tumors depends on the formation of new blood vessels. In contrast to genetically unstable tumor cells, the endothelial cells of tumor vessels are considered to be normal diploid cells that do not acquire mutations.
METHODS: Using a combined immunohistochemical and fluorescence in situ hybridization assay, we examined the endothelial cells in 27 B-cell lymphomas for cytogenetic alterations that are known to be present in the lymphoma cells.
RESULTS: We found that 15 to 85 percent (median, 37 percent) of the microvascular endothelial cells in the B-cell lymphomas harbored lymphoma-specific chromosomal translocations. In addition, numerical chromosomal aberrations were shared by the lymphoma cells and the endothelial cells.
CONCLUSIONS: Our findings suggest that microvascular endothelial cells in B-cell lymphomas are in part tumor-related and therefore reflect a novel aspect of tumor angiogenesis. Copyright 2004 Massachusetts Medical Society

Entities:  

Mesh:

Year:  2004        PMID: 15254283     DOI: 10.1056/NEJMoa033153

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  95 in total

Review 1.  Metronomic chemotherapy: new rationale for new directions.

Authors:  Eddy Pasquier; Maria Kavallaris; Nicolas André
Journal:  Nat Rev Clin Oncol       Date:  2010-06-08       Impact factor: 66.675

2.  Cancer: Tumour stem cells switch sides.

Authors:  Victoria L Bautch
Journal:  Nature       Date:  2010-12-09       Impact factor: 49.962

Review 3.  Involvement of non-vascular stem cells in blood vessel formation.

Authors:  Nobuyuki Takakura
Journal:  Int J Hematol       Date:  2012-02-04       Impact factor: 2.490

4.  Angiogenesis in nodal B cell lymphomas: a high throughput study.

Authors:  Alexandar Tzankov; Simone Heiss; Stephanie Ebner; William Sterlacci; Georg Schaefer; Florian Augustin; Michael Fiegl; Stephan Dirnhofer
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

5.  The expression and bioinformatic analysis of a novel gene C20orf14 associated with lymphoma.

Authors:  Liangping Su; Deng Chen; Jianming Zhang; Ximing Li; Guihong Pan; Xiangyang Bai; Yunping Lu; Jianfeng Zhou; Shuang Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-02

6.  The vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor cediranib (Recentin; AZD2171) inhibits endothelial cell function and growth of human renal tumor xenografts.

Authors:  Dietmar W Siemann; W D Brazelle; Juliane M Jürgensmeier
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-01       Impact factor: 7.038

7.  Adult human circulating CD34⁻Lin⁻CD45⁻CD133⁻ cells can differentiate into hematopoietic and endothelial cells.

Authors:  Elisa Ciraci; Silvia Della Bella; Ombretta Salvucci; Cristina Rofani; Marta Segarra; Caterina Bason; Agnese Molinari; Dragan Maric; Giovanna Tosato; Anna C Berardi
Journal:  Blood       Date:  2011-06-29       Impact factor: 22.113

8.  Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates.

Authors:  Sonja Loges; Thomas Schmidt; Peter Carmeliet
Journal:  Genes Cancer       Date:  2010-01

9.  The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome.

Authors:  Selcuk Sozer; Maria Isabel Fiel; Thomas Schiano; Mingjiang Xu; John Mascarenhas; Ronald Hoffman
Journal:  Blood       Date:  2009-03-17       Impact factor: 22.113

10.  Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential.

Authors:  Ines Martin-Padura; Paola Marighetti; Giuliana Gregato; Alice Agliano; Omar Malazzi; Patrizia Mancuso; Giancarlo Pruneri; Andrea Viale; Francesco Bertolini
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.